Malignant neoplam

Clinical trials for Malignant neoplam explained in plain language.

Never miss a new study

Get alerted when new Malignant neoplam trials appear

Sign up with your email to follow new studies for Malignant neoplam, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new Immune-Boosting drug shrink advanced solid tumors?

Disease control Not yet recruiting

This Phase 2 trial tests an investigational drug called MK-2010, which is designed to help the immune system attack cancer. Researchers will give MK-2010 alone or in combination with other treatments to about 480 people with advanced solid tumors, meaning cancers that have spread…

Matched conditions: MALIGNANT NEOPLAM

Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Sep 02, 2026 00:00 UTC

Malignant neoplam

Get alerted when new Malignant neoplam trials appear

Can a new Immune-Boosting drug shrink advanced solid tumors?